Hydrochlorothiazide Completed Phase 3 Trials for Atherosclerotic Cardiovascular Diseases / Hypertension,Essential Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02466490Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension
NCT00430950Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
NCT00902538Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
NCT00430508Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
NCT00220233Olmesartan as an add-on to Amlodipine in Hypertension
NCT00139698Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
NCT00996281Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
NCT00185185Olmesartan Medoxomil in Atherosclerosis
NCT00185172Olmesartan in Essential Hypertension
NCT00667719A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Patients With Essential Hypertension
NCT00751751Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly
NCT00818883Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
NCT00846365Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
NCT00872586Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
NCT01033071Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
NCT01113047Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine
NCT02277691A Phase III Long-term Study of TAK-536TCH in Patients With Essential Hypertension
NCT02738632Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients